Can a uterine fibroid cause lower‑extremity venous insufficiency?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 8, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Can a Uterine Fibroid Cause Lower Extremity Venous Insufficiency?

Yes, large uterine fibroids can cause lower extremity venous insufficiency through mechanical compression of the inferior vena cava (IVC) or iliac veins, leading to venous stasis and potentially life-threatening thromboembolism.

Mechanism and Clinical Evidence

Large uterine fibroids can directly compress major venous structures, particularly the IVC and iliac veins, creating mechanical obstruction that results in venous stasis and subsequent thrombosis 1, 2. This is a well-documented phenomenon in the literature, though relatively uncommon.

Key Clinical Characteristics

When fibroids cause venous complications, they typically demonstrate specific features:

  • Uterine size: Average 22.9 ± 5.0 weeks gestational age equivalent
  • Fibroid volume: Median ~2,715 cm³ (range 1,296-3,878 cm³)
  • Laterality: 60% of venous thromboembolisms (VTE) occur on the left side
  • Imaging findings: 87% show direct venous compression on imaging 2

The left-sided predominance occurs because the left iliac vein crosses beneath the right iliac artery before joining the IVC, making it more susceptible to compression by pelvic masses.

Clinical Presentation

Patients may present with:

  • Unilateral lower extremity swelling and pain (most common)
  • Recurrent unprovoked DVT despite anticoagulation 1
  • Phlegmasia cerulea dolens (severe cases) 3, 4
  • Pulmonary embolism 1, 5
  • Compartment syndrome (rare, severe cases) 4

Critical pitfall: These patients often have few traditional VTE risk factors, and the gynecological cause may be overlooked during initial workup 1, 6.

Diagnostic Approach

When evaluating unexplained or recurrent lower extremity venous insufficiency in women of reproductive age:

  1. Perform duplex ultrasound of the lower extremity to confirm thrombosis
  2. Obtain cross-sectional imaging (CT or MRI) to assess for pelvic masses and direct venous compression
  3. Look specifically for:
    • Uterine enlargement beyond normal size
    • Direct compression of IVC or iliac veins
    • Crescent-shaped or flattened appearance of compressed veins 7
    • Collateral venous pathways

Management

Surgical management is required in 89% of cases to relieve venous compression 2. Medical anticoagulation alone is insufficient when mechanical compression persists.

Treatment Algorithm

  1. Acute phase:

    • Initiate anticoagulation immediately
    • Consider IVC filter placement preoperatively if high PE risk 6
    • In severe cases (phlegmasia cerulea dolens), mechanical thrombectomy may be necessary before definitive surgery 3, 4
  2. Definitive treatment:

    • Hysterectomy is the most common definitive intervention (removes compression source)
    • Surgery should be performed urgently once patient is stabilized
    • Intraoperative assessment of venous patency is recommended 7
  3. Postoperative:

    • Continue anticoagulation until thrombus resolves
    • Transition to oral anticoagulants as appropriate 5
    • Symptoms typically resolve after fibroid removal 7, 6

Important Caveat Regarding Conservative Fibroid Treatments

While the ACR guidelines discuss various uterine-sparing options for symptomatic fibroids (UAE, MRgFUS, myomectomy) 8, these may not adequately address acute venous compression. When mechanical compression of major vessels is present with thrombosis, hysterectomy provides immediate and definitive relief of the obstruction.

Evidence Limitations

There is currently no evidence supporting prophylactic anticoagulation for patients with large fibroids without established thrombosis 2. The decision to anticoagulate prophylactically must weigh individual risk factors, though this remains an area requiring further research.

Additionally, while pelvic vein embolization is effective for pelvic congestion syndrome 9, 10, there is little evidence supporting its use for lower extremity varicose veins of pelvic origin when caused by fibroid compression 9.

Clinical Bottom Line

In any woman presenting with unexplained or recurrent lower extremity DVT, particularly left-sided, always obtain pelvic imaging to exclude large uterine fibroids causing mechanical venous compression. When compression is confirmed, surgical removal of the fibroid (typically hysterectomy) is necessary to prevent recurrent thrombosis, as anticoagulation alone cannot address the mechanical obstruction 1, 2.

References

Research

A Case Series of Patients with Large Uterine Fibroids and Venous Thromboembolisms.

Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC, 2021

Research

Phlegmasia cerulea dolens and compartment syndrome secondary to uterine lipoleiomyoma.

Journal of vascular surgery cases and innovative techniques, 2026

Guideline

acr appropriateness criteria® management of uterine fibroids: 2023 update.

Journal of the American College of Radiology, 2024

Guideline

acr appropriateness criteria® lower extremity chronic venous disease.

Journal of the American College of Radiology, 2023

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.